Navivumab, CAS 1443004-16-7

Product Description: Navivumab (CT-P23) is an influenza A virus hemagglutinin HA monoclonal antibody. neutralizes H1, H2, H5, and H9 influenza A viruses by binding to the stem fusion domain in HA2[1].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Beigel JH. Polyclonal and monoclonal antibodies for the treatment of influenza. Curr Opin Infect Dis. 2018 Dec;31(6):527-534.

CAS Number: 1443004-16-7

Molecular Weight: N/A

Compound Purity: 99.10

Research Area: Infection

Solubility: 10 mM in DMSO

Target: Influenza Virus

• SKU: MEXHY-P99750-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99750-5
• Package Unit: 5 mg
• Quantity Unit: STK
• Conjugate: Unconjugated